LYELL IMMUNOPHARMA INC (LYEL) Institutional Ownership and Insiders Activity
LYELL IMMUNOPHARMA INC (LYEL) is widely held by institutional investors, with 97 firms reporting positions valued at approximately $178.21M based on SEC Form 13F filings for the quarter ended June 30, 2026.
Arch Venture Management, Llc is the largest disclosed holder, reporting approximately $45.53M in LYEL holdings in its latest filing.
Recent insider activity includes 18 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
97
Total Reported Value
$178.21M
Largest Holder
Arch Venture Management, Llc
Largest Position
$45.53M
Insider Transactions (90d)
18
Latest Filing Quarter
Q2 2026
New Institutional Positions
62
Funds Exiting Positions
1
Top Institutional Owners
View allInvestorReported Balance
- Arch Venture Management, Llc$45.53M
- Gsk Plc$21.25M
- Vanguard Capital Management Llc$11.05M
- Orland Properties Ltd$10.60M
- Blackrock, Inc.$10.18M
Related LYEL Institutional Insights:
- LYEL 13F Institutional Holders
- LYEL Superinvestors
- LYEL Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- LYEL Insider Trading & SEC Form 4 Activity
- LYEL Articles
- Top Institutional Investor Stock Rankings